Celltrion Pharm

Celltrion Pharm EBIT Margin

The EBIT Margin (Operating Margin) of Celltrion Pharm (068760.KQ) as of Nov 4, 2026 is 10.46 %. In the previous year, EBIT Margin (Operating Margin) was 7.79 % — a change of 34.24% (higher).

EBIT Margin

10.46 %

YoY

34.24%

Last updated:

EBIT Margin (Operating Margin) of Celltrion Pharm is 2025 10.46 % . EBIT Margin (Operating Margin) of Celltrion Pharm was 2024 7.79 % . It decreases by 34.24% higher compared to the previous year.

For Celltrion Pharm, the operating (EBIT) margin of 10.5% is down versus 12.0% a few years ago.

The Celltrion Pharm EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-0.23 KRW
Jan 1, 2019
7.81 KRW
Jan 1, 2020
10.12 KRW
Jan 1, 2021
11.99 KRW
Jan 1, 2022
9.89 KRW
Jan 1, 2023
8.59 KRW
Jan 1, 2024
7.79 KRW
Jan 1, 2025
10.46 KRW
The Celltrion Pharm EBIT Margin history
YEAREBIT MarginYoY
10.46 %+34.24%
7.79 %-9.33%
8.59 %-13.11%
9.89 %-17.52%
11.99 %+18.49%
10.12 %+29.53%
7.81 %-3,545.50%
-0.23 %-103.55%
6.38 %-7.98%
6.94 %-18.69%
8.53 %-31.82%
12.51 %+8,691.07%
0.14 %+31.59%
0.11 %-17.76%
0.13 %-32.35%
0.19 %-1,942.81%
-0.01 %-95.25%
-0.22 %-303.64%
0.11 %-39.68%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celltrion Pharm Stock analysis

What does Celltrion Pharm do? Celltrion Pharm, Inc. generates revenue through the manufacture and sale of pharmaceutical products including hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. The company distributes ethical drugs and over-the-counter (OTC) drugs domestically and in overseas markets such as the Philippines, Kazakhstan, Cambodia, and other Southeast Asia countries. Its product portfolio targets healthcare providers and consumers seeking both prescription and non-prescription medications across multiple therapeutic categories. The firm's revenue streams are derived from sales of its diverse pharmaceutical offerings in both domestic and international markets. Products such as antibiotics and respiratory apparatus drugs are sold to healthcare institutions and pharmacies, while OTC drugs like analgesics and antihistamines reach retail consumers directly. The company's presence in Southeast Asia, particularly in the Philippines, Kazakhstan, and Cambodia, supports its international sales strategy. Celltrion Pharm, Inc. serves healthcare professionals and consumers through its domestic market operations and international distribution channels. Its product range spans multiple therapeutic areas, from digestive health to respiratory treatments, catering to both institutional and individual buyers. The company's focus on both ethical and OTC pharmaceuticals allows it to capture revenue from various segments within the healthcare industry. Celltrion Pharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celltrion Pharm stock

EBIT Margin (Operating Margin) of Celltrion Pharm is 10.46 % in 2025.

EBIT Margin (Operating Margin) of Celltrion Pharm changed from 7.79 % to 10.46 %, representing a 34.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Celltrion Pharm since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Celltrion Pharm with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Celltrion Pharm

All Key Metrics — Celltrion Pharm